Sung Joo Lee, Orum Therapeutics CEO
July 16, 2024 07:00 AM EDT
Startups
Deals
Cell/Gene Tx

Af­ter last year's Im­muno­Gen pact, Ver­tex finds an­oth­er con­di­tion­ing agent part­ner in Orum

Kyle LaHucik

Senior Reporter

Ver­tex is part­ner­ing with a US and South Ko­re­an biotech to see if it can of­fer pa­tients a bet­ter con­di­tion­ing agent to make way for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times